IRIS
VACCA, Angelo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 30.773
EU - Europa 7.062
AS - Asia 3.208
SA - Sud America 18
AF - Africa 16
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 10
Totale 41.101
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 30.751
CN - Cina 2.339
SE - Svezia 2.124
IT - Italia 1.372
UA - Ucraina 937
DE - Germania 903
FI - Finlandia 599
SG - Singapore 564
GB - Regno Unito 501
FR - Francia 233
BE - Belgio 115
IN - India 108
IE - Irlanda 90
VN - Vietnam 79
CZ - Repubblica Ceca 52
RU - Federazione Russa 40
JP - Giappone 30
KR - Corea 23
IR - Iran 22
CA - Canada 21
NL - Olanda 21
PL - Polonia 15
EU - Europa 14
ES - Italia 11
EG - Egitto 10
AU - Australia 8
PH - Filippine 8
AT - Austria 7
CH - Svizzera 7
HK - Hong Kong 7
CL - Cile 6
IL - Israele 5
BD - Bangladesh 4
BR - Brasile 4
ID - Indonesia 4
MY - Malesia 4
BG - Bulgaria 3
EE - Estonia 3
HR - Croazia 3
HU - Ungheria 3
MK - Macedonia 3
RO - Romania 3
TR - Turchia 3
AR - Argentina 2
DK - Danimarca 2
DZ - Algeria 2
EC - Ecuador 2
GR - Grecia 2
LT - Lituania 2
LU - Lussemburgo 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
RS - Serbia 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AZ - Azerbaigian 1
BJ - Benin 1
BT - Bhutan 1
BY - Bielorussia 1
CO - Colombia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MD - Moldavia 1
MW - Malawi 1
MX - Messico 1
NG - Nigeria 1
PE - Perù 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 41.101
Salva come PNG Salva come JPEG
Città #
Fairfield 4.235
Chandler 3.358
Woodbridge 3.084
Ashburn 2.269
Jacksonville 2.200
Houston 1.913
Seattle 1.743
Cambridge 1.589
Nyköping 1.484
Wilmington 1.410
Ann Arbor 1.341
Lawrence 667
Roxbury 666
Nanjing 611
New York 534
Singapore 471
Beijing 445
Des Moines 415
Bari 333
Princeton 322
Inglewood 276
San Diego 198
Boardman 163
Brooklyn 154
Nanchang 154
Shenyang 154
Dearborn 149
Hebei 137
Jiaxing 125
Santa Clara 124
Brussels 113
Tianjin 102
Los Angeles 100
London 98
Helsinki 91
Dublin 88
Grafing 84
Dong Ket 77
Changsha 76
Pune 67
Rome 67
Washington 67
Marseille 64
Redwood City 61
Paris 58
Guangzhou 57
Munich 51
Milan 45
Brno 43
Leawood 37
Jinan 35
Augusta 30
Norwalk 29
Shanghai 28
Hefei 27
Kunming 27
Auburn Hills 26
Kilburn 25
Zhengzhou 24
Ningbo 23
Brescia 21
San Mateo 21
Wuhan 21
Falls Church 19
Ardabil 18
Osaka 17
Taizhou 16
Wuxi 16
Monmouth Junction 15
Santa Marinella 15
Triggiano 14
Catania 13
Chicago 13
Florence 13
Hounslow 13
Toronto 13
Padova 12
Tappahannock 12
Torrile 12
Hangzhou 10
Naples 10
Redmond 10
Acton 9
Islington 9
Modugno 9
Mumbai 9
New Bedfont 9
Prescot 9
Aversa 8
Chiswick 8
Cutrofiano 8
Nürnberg 8
Baotou 7
Barletta 7
Fuzhou 7
Grottaglie 7
Olomouc 7
San Francisco 7
Sannicandro di Bari 7
Simi Valley 7
Totale 32.910
Salva come PNG Salva come JPEG
Nome #
Significato clinico dell’interleuchina-2 (IL-2) e del suo recettore solubile nelle gammapatie monoclonali e nella crioglobulinemia mista essenziale 361
Adhesion-Mediated Multiple Myeloma (MM) Disease Progression: Junctional Adhesion Molecule a Enhances Angiogenesis and Multiple Myeloma Dissemination and Predicts Poor Survival 224
Le tecniche immunoenzimatiche in immunoistochimica. L’immunoperossidasi e l’immunofosfatasi alcalina 158
Pemphigus and mucous membrane pemphigoid: An update from diagnosis to therapy 149
Central Function for JAM-a in Multiple Myeloma Patients with Extramedullary Disease. 141
Isolation and characterization of neural stem cells from dystrophic mdx mouse 136
Targeting B-cell non Hodgkin lymphoma: New and old tricks 134
18F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders 132
Bone marrow endothelial cells sustain a tumor-specific CD8+ T cell subset with suppressive function in myeloma patients 131
Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies 130
Role of HDL and uric acid in vascular damage in well-controlled 128
Role of endothelial cells and fibroblasts in multiple myeloma angiogenic switch 126
The small subunit of Hemilipin2, a new heterodimeric phospholipase A2 from Hemiscorpius lepturus scorpion venom, mediates the antiangiogenic effect of the whole protein 126
Extramedullary Plasmacytoma Mimicking Pancreatic Cancer: An Unusual Presentation 126
Translational impact of novel widely pharmacological characterized mofezolac-derived COX-1 inhibitors combined with bortezomib on human multiple myeloma cell lines viability 126
Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes 122
Analysis of aortic remodeling and stiffness in patients with obstructive sleep apnea syndrome: Preliminary results 122
Microenvironment drug resistance in multiple myeloma: Emerging new players 120
Antibody V(h) repertoire differences between resolving and chronically evolving hepatitis C virus infections 118
Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets 118
Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis 118
JAM-A as a Prognostic Factor and New Therapeutic Target in Multiple Myeloma 117
JAM-A as a prognostic factor and new therapeutic target in multiple myeloma 116
Involvement of NOTCH signaling in multiple myeloma angiogenesis and progression 115
Translocation of the proto-oncogene Bcl-6 in human glioblastoma multiforme 114
Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview 114
Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma 113
Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients 111
Filgrastim, lenograstim and pegfilgrastim in the mobilization of peripheral blood progenitor cells in patients with lymphoproliferative malignancies 110
Survivin overexpression in head and neck squamous cell carcinomas as a new therapeutic target (Review) 110
Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: Clinical results and effects on microenvironment and neo-angiogenic biomarkers 110
Early echocardiographic detection of left ventricular diastolic dysfunction in patients with systemic lupus erythematosus asymptomatic for cardiovascular disease 110
Multiple Myeloma as a model for the role of bone marrow niches in the control of angiogenesis 110
A Mini-Review on Thalidomide: Chemistry, Mechanisms of Action, Therapeutic Potential and Anti-Angiogenic Properties in Multiple Myeloma 110
Evidence for bone marrow adult stem cell plasticity: Properties, molecular mechanisms, negative aspects, and clinical applications of hematopoietic and mesenchymal stem cells transdifferentiation 109
Improving knowledge on the activation of bone marrow fibroblasts in MGUS and MM disease through the automatic extraction of genes via a nonnegative matrix factorization approach on gene expression profiles. 108
Identify multiple myeloma stem cells: Utopia? 108
Suspected Pericardial Tuberculosis Revealed as an Amyloid Pericardial Mass 108
Functional and biological role of endothelial precursor cells in tumour progression: A new potential therapeutic target in haematological malignancies 107
Multiple myeloma macrophages: Pivotal players in the tumor microenvironment 107
Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma 105
Management of common variable immunodeficiency by subcutaneous IgG self-administration during pregnancy - a case report 105
Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing 105
Jejunal overexpression of peptide YY in celiac disease complicated with pneumatosis cystoides intestinalis 104
Ocular Involvement in Systemic Lupus Erythematosus: The Experience of Two Tertiary Referral Centers 104
"Real world" outcome of lenalidomide plus dexamethasone in the setting of recurrent and refractory multiple myeloma: Extended follow-up of a retrospective multicenter study by the "rete ematologica pugliese" 103
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment 103
A possible role of tryptase in angiogenesis in the brain of mdx mouse, a model of Duchenne muscular dystrophy 101
null 101
Neutropenia and G-CSF in lymphoproliferative diseases 101
Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients 101
Cancer Associated Fibroblasts and Tumor Growth: Focus on Multiple Myeloma 100
Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial 100
Dendritic cell maturation in HCV infection: Altered regulation of MHC class I antigen processing-presenting machinery 99
Echocardiographic findings and plasma endothelin-1 levels in obese patients with and without obstructive sleep apnea 99
Correlations between severity of obstructive sleep apnoea and systolic pulmonary artery pressure: preliminary results 99
Delayed complete remission in a patient with multiple myeloma 98
Targeting vasculogenesis to prevent progression in multiple myeloma 98
Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma 98
The role of the vascular phase in solid tumor growth: a historical review 97
Acquired C1-inhibitor deficiency in a patient with systemic lupus erythematosus: a case report and review of the literature 97
MHC Class i Antigen Processing and Presenting Machinery: Organization, Function, and Defects in Tumor Cells 96
Pharmacological activation of protein phosphatase 2 A (PP2A): A novel strategy to fight against human malignancies? 96
Modifications of the mouse bone marrow microenvironment favor angiogenesis and correlate with disease progression from asymptomatic to symptomatic multiple myeloma. 95
Common variable immunodeficiency and gastric malignancies 95
Direct and Indirect Costs of Immunoglobulin Replacement Therapy in Patients with Common Variable Immunodeficiency (CVID) and X-Linked Agammaglobulinemia (XLA) in Italy 95
Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma–Enhanced Angiogenesis: A Novel Therapeutic Target? 95
Myeloma cells act as tolerogenic antigen-presenting cells and induce regulatory T cells in vitro 95
Is the localized seminal plasma hypersensitivity the mucosal aspect of protein contact dermatitis? 95
Angiogenesis in neuroblastoma 94
Vascular Endothelial Growth Factor and its Receptors in Multiple Myeloma 94
Vascular endothelial growth factor and tryptase changes after chemoembolization in hepatocarcinoma patients 94
Metronomic chemotherapy from rationale to clinical studies: A dream or reality? 94
Angiogenesis during tumor progression in human malignant melanoma 93
Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma 93
Angiogenesis and anti-angiogenesis in neuroblastoma 93
Dyspnea, Fatigue, and Generalized Weakness in a 67-Year-Old Man: Approach to the Patient Between Guidelines and Clinical Judgment 93
Cancer treatment and the KIR–HLA system: an overview 93
Hemilipin, a novel Hemiscorpius lepturus venom heterodimeric phospholipase A2, which inhibits angiogenesis in vitro and in vivo 93
Phthalimide Derivative Shows Anti-angiogenic Activity in a 3D Microfluidic Model and No Teratogenicity in Zebrafish Embryos 93
Multiple myeloma and mycosis fungoides in the same patient: clinical, immunologic and molecular studies 92
Halting prosurvival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes Bortezomid resistance in multiple myeloma patients. 92
Inflammation and antiangiogenesis in cancer 91
Vasculitis in connective tissue diseases 90
Direct-acting antiviral agents in the therapy of hepatitis C virus-related mixed cryoglobulinaemia: a single-centre experience 90
Thalidomide: a new anticancer drug? 89
Angiogenesis and vasculogenesis in multiple myeloma: role of inflammatory cells 89
Monocyte-macrophage system and polymorphonuclear leukocytes in workers exposed to low levels of metallic mercury 89
Autoimmune uveitis: a retrospective analysis of 104 patients from a tertiary reference center 89
Multiple myeloma exosomes establish a favourable bone marrow microenvironment with enhanced angiogenesis and immunosuppression 89
Belimumab restores Treg/Th17 balance in patients with refractory systemic lupus erythematosus 89
Intelligent microarray data analysis through non-negative matrix factorization to study human multiple myeloma cell lines 89
Lipoprotein(a) induces angiogenesis on the chick embryo chorioallantoic membrane 88
Proteolytic activity of human lymphoid tumor cells. Correlation with tumor progression 88
Angiogenesis in multiple myeloma 88
null 87
Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with upgrading and myometrial invasion in endometrial carcinoma 87
Granulomatosis with polyangiitis (Wegener's) 87
Emerging Concepts in Acute Heart Failure: From the Pathophysiology to the Clinical Case Based Approach 87
Latex immunotherapy: State of the art 86
Totale 10.836
Salva come PNG Salva come JPEG
Categoria #
all - tutte 188.123
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 188.123
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208.194 0 0 342 901 1.089 713 1.141 958 1.293 577 864 316
2020/20217.142 581 411 562 480 1.039 385 595 529 640 880 550 490
2021/20224.969 301 658 73 208 246 286 283 268 299 372 813 1.162
2022/20238.129 1.194 888 512 755 866 1.173 89 831 1.413 66 187 155
2023/20243.055 256 542 167 184 280 917 94 156 17 78 46 318
2024/20251.340 340 193 807 0 0 0 0 0 0 0 0 0
Totale 42.590